DarioHealth Enters into Strategic Agreement with Sanofi U.S.

NEW YORK, March 1, 2022 /PRNewswire/ — DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced it has entered into a strategic agreement with Sanofi U.S., an innovative global healthcare company. The multi-year, $30 million-dollar agreement,…

About the Author

has written 20652 stories on this site.

Copyright © 2010-2019 strategicbusinessnews.com